Explore more publications!

Guyana Health Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guyana Health Review.

Press releases published on November 12, 2025

Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204
Aprea Therapeutics Reports Third quarter 2025 Financial Results and Provides a Clinical Update
Jushi Holdings Inc. Announces Grand Opening of Beyond Hello™ Little Ferry in New Jersey
Evaxion announce 2026 financial calendar
Picard to Attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum November 20, 2025, in New York City
LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer
Essity et sa marque JOBST® font équipe avec les Raptors de Toronto pour prouver que « Les armures ne sont pas toutes faites d'acier »
Collegium to Participate in Upcoming Investor Conferences
Essity Brand, JOBST®, Teams Up with Toronto Raptors to Prove that “Not All Armour is Made of Steel”
The C3i Center welcomes Bobby Boursiquot as its new Vice President of Commercialization
Le Centre C3i accueille Bobby Boursiquot en tant que nouveau vice-président chargé de la commercialisation
PMV Pharmaceuticals Reports Third Quarter 2025 Financial Results and Corporate Highlights
BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates
PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results
ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team
Velocity Clinical Research Appoints Former Fortrea Executive, Andrew Reina, as Chief Revenue Officer
Zenas BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Milestone Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Regulatory and Corporate Update
Monogram Health Announces New Executives to Oversee its U.S. Operations
Prelude Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions